Aims & Scope

Aims

Cardiogenetics (ISSN 2035-8148) is an international, peer-reviewed, open access journal that provides an advanced forum for studies related to all aspects of cardiogenetics (clinical, molecular, cellular, pharmacological). Cardiogenetics focuses on publishing reviews, regular research papers, communications, and case reports, but other article types will also be considered. Submissions should focus on the intersection of cardiovascular medicine and genetics. There are no restrictions on the maximum length of papers. All research must provide sufficient methodological detail to ensure reproducibility of results.

Scope

As an essential resource to general physicians, cardiologists, and geneticists, Cardiogenetics’ primary purpose is to publish papers on the following topics:

- Clinical and molecular aspects of inherited heart diseases: genotype–phenotype findings; follow-up data from inherited heart disease clinics; clinical findings from large and informative families with inherited heart diseases; and studies on molecular imaging in inherited heart diseases.

- Clinical and molecular aspects of rare diseases with cardiovascular involvement: clinical imaging and molecular findings of rare genetic disorders that affect the heart and vasculature.

- Pharmacogenetics and pharmacogenomics in cardiovascular medicine: studies involving new drugs or well-known therapies in inherited heart diseases, rare diseases, and cardiovascular medicine; and genetic/genomic profile and response to therapies.

- Stem cells and regenerative therapies for genetic heart diseases: clinical trials and experimental studies involving cell studies/cell therapy, including gene editing in stem cells for cardiac repair.

- Diagnostic methods for cardiogenetic disorders: including but not limited to next-generation sequencing, comparative microarray analysis (CMA), optical genome mapping (OGM), and other techniques for the interrogation of genomic variants and events, variant interpretation, functional assays, and non-invasive imaging techniques specifically applied to inherited heart conditions.

- Bioinformatics and statistical genetics in heart disease: methods for analyzing cardiogenetic data, polygenic risk scores for cardiovascular traits, and computational approaches to identify heart disease-associated variants.

- Personalized medicine and gene-targeted therapies: gene therapy, antisense oligonucleotides, and gene editing (e.g., CRISPR) for inherited cardiovascular diseases.

- Molecular biology and pathophysiology of genetic and genomic cardiovascular diseases: biology of cells; pathways and systems; epigenetics and gene regulation; and biology and pathophysiology of specific genes and non-coding DNA.

- Polygenic/multifactorial cardiovascular disorders.

- Cellular electrophysiological studies related to inherited arrhythmogenic conditions.

- Cardiovascular imaging in the context of genetic disease.

- Mutation reports: descriptions of novel or potentially pathogenic variants in genes associated with cardiovascular phenotypes, with supporting family or functional data.

A space will be given to negative studies in cardiogenetics: this space will be dedicated to clinical, molecular, cellular, and pharmacological studies with a solid scientific background that lead to negative results.

MDPI Publication Ethics Statement

MDPI is a member of the Committee on Publication Ethics (COPE). MDPI takes the responsibility to enforce a rigorous peer-review together with strict ethical policies and standards to ensure to add high quality scientific works to the field of scholarly publication. Unfortunately, cases of plagiarism, data falsification, inappropriate authorship credit, and the like, do arise. MDPI takes such publishing ethics issues very seriously and our editors are trained to proceed in such cases with a zero tolerance policy. To verify the originality of content submitted to our journals, we use iThenticate to check submissions against previous publications.

Book Reviews

Authors and publishers are encouraged to send review copies of their recent related books to the following address. Received books will be listed as Books Received within the journal's News & Announcements section.

MDPI
Grosspeteranlage 5
CH-4052 Basel
Switzerland

Copyright / Open Access

Articles published in Cardiogenetics will be Open-Access articles distributed under the terms and conditions of the Creative Commons Attribution License (CC BY). The copyright is retained by the author(s). MDPI will insert the following note at the end of the published text:

Reprints

Reprints may be ordered. Please contact publisher@mdpi.com for more information on how to order reprints.

Announcement and Advertisement

Announcements regarding academic activities such as conferences are published for free in the News & Announcements section of the journal. Advertisement can be either published or placed on the pertinent website. Contact e-mail address is cardiogenetics@mdpi.com.